| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman | Executive Chairman +1 more
2 companies
El-Hibri Fuad is a Director at Emergent BioSolutions Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 12 sells.
Estimated insider holdings value: $25.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2020 | EBS Emergent Biosolutions Inc. | Chairman | Sell | 42,576 | $60.59 | $2,579,575.36 | -1.5% | |
| Feb 27, 2020 | EBS Emergent Biosolutions Inc. | Chairman | Sale+OE | 23,456 | $57.97 | $1,359,849.19 | -0.8% | |
| Feb 21, 2020 | EBS Emergent Biosolutions Inc. | Chairman | Sale+OE | 23,318 | $64.90 | $1,513,338.20 | -0.8% | |
| Feb 18, 2020 | EBS Emergent Biosolutions Inc. | Chairman | Sale+OE | 20,000 | $63.90 | $1,278,000.00 | -0.7% | |
| Feb 12, 2020 | EBS Emergent Biosolutions Inc. | Chairman | Sale+OE | 20,000 | $62.90 | $1,258,000.00 | -0.7% | |
| Feb 6, 2020 | EBS Emergent Biosolutions Inc. | Executive Chairman | Sell | 60,000 | $60.90 | $3,654,088.16 | -2.1% | |
| Aug 12, 2019 | APVO Aptevo Therapeutics Inc. | Director | Buy | 100,000 | $0.76 | $75,520.00 | +9.8% | |
| Jul 29, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 55,015 | $0.83 | $45,860.50 | +5.7% | |
| Jul 23, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 10,000 | $0.90 | $8,996.00 | +1.0% | |
| Jul 22, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 30,000 | $0.89 | $26,601.00 | +3.2% |